Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04032106 · ClinicalTrials.gov registry record · NA
HPV Vaccine Intervention for Young Sexual Minority Men
A NA study, sponsored by Ohio State University Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 1,227
- Enrollment target
NCT04032106 is a NA study that has completed, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 1,227 participants.
The verdict
NCT04032106, a NA study, has completed, sponsored by Ohio State University Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,227 participants
- Enrollment target
Study Summary
This phase III trial studies how well the Outsmart HPV intervention works in increasing HPV vaccine initiation and completion among young individuals who report having a history of same-sex partners, being sexually attracted to males, or identify as gay, bisexual, or queer (i.e., sexual minority males). The Outsmart HPV intervention, which is a population-targeted, individually-tailored mHealth intervention that includes vaccine reminders, may increase HPV vaccine initiation and completion among unvaccinated young sexual minority individuals.
Interventions
- OTHER Questionnaire Administration
- OTHER Best Practice
- OTHER Informational Intervention
- BEHAVIORAL Text Message-Based Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,227 participants |
| Start Date | 2019-10-03 |
| Est. Completion | 2022-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04032106
The ClinicalTrials.gov registry entry for NCT04032106 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,227 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University Comprehensive Cancer Center, which has 341 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Questionnaire Administration is the first listed.
NCT04032106 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04032106 about?
NCT04032106 is a clinical study titled "HPV Vaccine Intervention for Young Sexual Minority Men". This phase III trial studies how well the Outsmart HPV intervention works in increasing HPV vaccine initiation and completion among young individuals who report having a history of same-sex partners, being sexually attracted to males, or identify as gay, bisexual, or queer (i.e., sexual minority mal...
What is the current status of trial NCT04032106?
This trial is currently completed. It is a NA study. The enrollment target is 1,227 participants. The study started on 2019-10-03. Estimated completion is 2022-03-31.
What interventions are being tested in trial NCT04032106?
The interventions under investigation include: Questionnaire Administration (OTHER), Best Practice (OTHER), Informational Intervention (OTHER), Text Message-Based Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT04032106?
This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.